Multiplex bead assay technology relies on the ability of flow cytometers to separate beads covalently coupled to antibodies based on their size and fluorescence intensity. Replacement of traditional ELISA with multiplex immunoassays allows for simultaneous evaluation of multiple analytes using minimal sample volume and offers cost-effective and convenient quantification of biological markers. Best of all, multiplex assaysdo not require special instrumentation and work on the convenient, affordable, dual-laser BD Accuri C6.
Resources: